The Journal of Urology Vol. 200 (2018): October

Most Comprehensive and Affordable Self-study CME Product!

Make the most of your Journal of Urology® Subscription

Developed by a team of educators, academicians, and clinicians, this valuable home study activity will enhance your knowledge of urology and improve performance as well as patient care at your convenience. For just $2.50 per credit, the Home Study program is designed to provide urologists and residents affordable access to the most recent developments and techniques in urology while reading The Journal®.

Each month includes 5 clinically-relevant, selected articles with a corresponding online test for each of the 12 issues of The Journal®.

The American Urological Association designates this enduring material for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Home Study Course is available only to subscribers of The Journal of Urology® and includes volumes 199 and 200.

The 2015, 2016, and 2017 CME posttests are available online. The 2018 posttests will be posted online as they become available.

Target Audience

This course is designed for:

  • Practicing Urologists
  • American Board of Urology (ABU) candidates
  • Residents

Learning Objectives

After completing each lesson, the participants should be able to:

  1. Assess their knowledge of urology
  2. Demonstrate an increased knowledge base of urology
  3. Apply the increased knowledge to improve quality of patient care
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Course opens: 
10/01/2018
Course expires: 
10/31/2021

Disclosures

(Individuals in control of the content. All individuals with their respective disclosures listed in this document are planners. Individual authors’ disclosures are located with their articles in each issue of The Journal of Urology®.)

Planner Disclosures

Victor Nitti, MD: Astellas: Health Publishing, Scientific Study or Trial; Allergan: Health Publishing, Scientific Study or Trial; Serenity Pharmeuticals: Investment Interest; Cook Myosite: Scientific Study or Trial
Brant Inman, MD, MS: Dendreon: Scientific Study or Trial; Abbott Laboratories: Scientific Study or Trial; Genentech, Inc.: Scientific Study or Trial; Combat Medical: Consultant or Advisor; FKD Therapies: Scientific Study or Trial; AstraZeneca: Consultant or Advisor; Taris Biomedical: Consultant or Advisor

The Journal of Urology® Editorial Board

NameCompanyRole
Anthony Atala MDPlureon IncLeadership Position
Duane D. Baldwin ,MDCook Urological, Inc.Meeting Participant or Lecturer
Olympus CorporationConsultant or Advisor
Bard Medical DivisonConsultant or Advisor
DARRTLeadership Position
StepLiteLeadership Position
PfizerInvestment Interest
Daniel Ari Barocas, MDAstra ZenecaMeeting Participant or Lecturer
TolmarConsultant or Advisor
Peter Colin Black, MDGenomeDx Biosciences IncConsultant or Advisor, Scientific Study or Trial
JanssenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
AstellasConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
AmgenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
SitkaConsultant or Advisor
AbbVieConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
BiosyentConsultant or Advisor
Bristol Myers SquibbConsultant or Advisor
PLOS ONEHealth Publishing
BMC UrologyHealth Publishing
MerckConsultant or Advisor
iProgenScientific Study or Trial
BayerConsultant or Advisor
New B InnovationScientific Study or Trial
RedLeaf MedicalMeeting Participant or Lecturer
BiocancellConsultant or Advisor
Roche/GenentechConsultant or Advisor, Scientific Study or Trial
World Journal of UrologyHealth Publishing
Urologic OncologyHealth Publishing
Bladder CancerHealth Publishing
Robert Edward Brannigan, MDThe American Society for Reproductive Medicine (ASRM)Leadership Position, Health Publishing
The American Society for Reproductive MedicineLeadership Position
The National Institutes of HealthOther
Rodney Henry Breau MDNothing to disclose 
Mark Patrick Cain MDNothing to disclose 
Toby C. Chai, MDNothing to disclose 
Craig Vance Comiter ,MDzenflowScientific Study or Trial
Avails medicalConsultant or Advisor
NeusperaConsultant or Advisor
BE technologiesScientific Study or Trial
Siamak Daneshmand, MDPhotocureConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
TarisConsultant or Advisor
Pacific EdgeConsultant or Advisor
Ithaar H. Derweesh, MDGlaxoSmithKline, Inc.Scientific Study or Trial
Pfizer, Inc.Scientific Study or Trial
Scott E. Eggener ,MDNxTheraConsultant or Advisor
Profound MedicalConsultant or Advisor
Genomic HealthConsultant or Advisor, Scientific Study or Trial
MDx HealthConsultant or Advisor, Meeting Participant or Lecturer
Opko HealthConsultant or Advisor, Scientific Study or Trial
Brian Howard Eisner, MDRavine GroupOwner, Product Development
Gyrus/ACMI/OlympusConsultant or Advisor
Boston ScientificConsultant or Advisor
BardConsultant or Advisor
RetrophinConsultant or Advisor
AllenaConsultant or Advisor
Kalera MedicalConsultant or Advisor
Howard B. Goldman, MDallerganConsultant or Advisor
MedtronicConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
CookScientific Study or Trial
NuvectraConsultant or Advisor
AxonicsConsultant or Advisor
NewUroConsultant or Advisor
Jason C. Hedges ,MD, PhDNothing to disclose 
Wayne John G. Hellstrom, MDEndoConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
TheralogixLeadership Position
ColoplastConsultant or Advisor, Meeting Participant or Lecturer
NIHLeadership Position
New England Research Institutes, IncOther
AbbvieConsultant or Advisor
PfizerConsultant or Advisor
AllerganConsultant or Advisor
Boston ScientificConsultant or Advisor
VirilityConsultant or Advisor
Ashish M. Kamat, MDFKDScientific Study or Trial
PhotocureConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
SanofiConsultant or Advisor, Meeting Participant or Lecturer
Abbott MolecularConsultant or Advisor
TheralaseConsultant or Advisor
Telesta Therapeutics Inc. (formerly Bioniche)Consultant or Advisor
Heat BiologicsConsultant or Advisor, Scientific Study or Trial
Pacific Edge, LtdMeeting Participant or Lecturer
MerckConsultant or Advisor, Scientific Study or Trial
Spectrum PharmaceuticalsConsultant or Advisor
OncogenixConsultant or Advisor
CepheidConsultant or Advisor
Melissa Rae Kaufman MDBoston ScientificConsultant or Advisor, Other
Cook MyositeOther
Simon Kim, MDNothing to disclose 
Laurence H. Klotz, MDFerringConsultant or Advisor, Scientific Study or Trial
AmgenConsultant or Advisor, Scientific Study or Trial
AstellasMeeting Participant or Lecturer, Scientific Study or Trial
MedivationMeeting Participant or Lecturer, Scientific Study or Trial
AbbvieMeeting Participant or Lecturer, Scientific Study or Trial
JanssenMeeting Participant or Lecturer, Scientific Study or Trial
Profound MedicalConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Badrinath R. Konety, MD, MBAPhotocure IncScientific Study or Trial
Genomic HealthScientific Study or Trial
NxThera IncConsultant or Advisor
MDX HealthConsultant or Advisor
Genentech/RocheScientific Study or Trial
FKD TherapeuticsScientific Study or Trial
Jaime Landman, MDCook UrologicalConsultant or Advisor, Owner, Product Development
Galil MedicalConsultant or Advisor
CONMEDConsultant or Advisor
AurisConsultant or Advisor, Investment Interest
AllerganScientific Study or Trial
Gary Evan Lemack ,MDAllerganConsultant or Advisor, Meeting Participant or Lecturer
RoivantConsultant or Advisor
Yair Lotan ,MDabbottScientific Study or Trial
CepheidConsultant or Advisor, Scientific Study or Trial
Pacific EdgeScientific Study or Trial
FKDScientific Study or Trial
MDxHealthConsultant or Advisor, Scientific Study or Trial
biocancellScientific Study or Trial
Genomic HealthScientific Study or Trial
GenomeDx Biosciences IncScientific Study or Trial
photocureConsultant or Advisor, Scientific Study or Trial
William Thomas Lowrance, MDMyriad GeneticsScientific Study or Trial
Genome DxScientific Study or Trial
ArgosScientific Study or Trial
Stream DxInvestment Interest
Kevin Thomas McVary, MD, FACSAstellasScientific Study or Trial
Lilly/ICOSConsultant or Advisor, Scientific Study or Trial, Other
NIDDKScientific Study or Trial
AMS/Boston ScientificConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
NeoTractConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
AstellasScientific Study or Trial
SophirisScientific Study or Trial
MerckConsultant or Advisor
Maxwell V. MengAUAHealth Publishing
Urologic Oncology (Journal)Health Publishing
David Christopher Miller, MD,MPHBlue Cross Blue Shield of MichiganOther
National Cancer InstituteScientific Study or Trial
Nicole Lara Miller ,MDBoston Scientific CorporationConsultant or Advisor, Meeting Participant or Lecturer
Practical Reviews In UrologyHealth Publishing
Joel Byron Nelson MDNothing to disclose 
John Luther Phillips, MDNothing to disclose 
Mrs.. Deborah F. PollyNothing to disclose 
Sanoj Punnen, MDGenome DxMeeting Participant or Lecturer
OPKO DiagnosticsScientific Study or Trial
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment Interest
Pacific Edge BiotechnologyConsultant or Advisor, Scientific Study or Trial
Bradley Fields Schwartz ,MDCook MedicalMeeting Participant or Lecturer
Ojas Shah, M.D.Boston ScientificConsultant or Advisor, Meeting Participant or Lecturer
ElsevierHealth Publishing
American Urological AssociationMeeting Participant or Lecturer, Other
Bristol Myers SquibbInvestment Interest
RetrophinConsultant or Advisor
Applaud MedicalConsultant or Advisor
NJ Kidney Stone CenterInvestment Interest
Glaxo Smith KlineInvestment Interest
NovartisInvestment Interest
Joseph A. Smith Jr.,MDNothing to disclose 
Kevan A. Sternberg ,MDThe Journal of UrologyLeadership Position
John T. Stoffel MDUroplastyScientific Study or Trial
PCORIScientific Study or Trial
Journal of urologyLeadership Position
Department of DefenseScientific Study or Trial
IpsenScientific Study or Trial
Ramakrishna VenkateshNothing to disclose 
Julian Hsin-Cheng Wan MDAllerganScientific Study or Trial
Journal of UrologyHealth Publishing

Accreditation

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American Urological Association designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

AUA Disclosure Policy

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/ or Education Content Review Committee or its subgroup
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point- counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty


Evidence-based Content

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Off label or Unapproved Use of Drugs or Devices

It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer

The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Release Date: October, 2018.

Expiration Date: October, 2021.

Copyright © 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Please login or register to take this course.